What is the recommended dosage of lignocaine (lidocaine) for local anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Lignocaine for Local Anesthesia

The maximum safe dose of lignocaine for local anesthesia is 7 mg/kg with epinephrine (not exceeding 500 mg total) and 4.5 mg/kg without epinephrine (not exceeding 300 mg total) for normal healthy adults. 1

Maximum Dosage Guidelines by Administration Route

For Infiltration and Peripheral Nerve Blocks:

  • Maximum dose with epinephrine: 7 mg/kg (not exceeding 500 mg total) 1
  • Maximum dose without epinephrine: 4.5 mg/kg (not exceeding 300 mg total) 1
  • For dilute solutions (0.4-0.5%), up to 500 mg plain lignocaine or 670 mg with adrenaline can be safely used 2

For Intravenous Regional Anesthesia:

  • Maximum dose: 4 mg/kg 1
  • For Bier block specifically: 3-5 mg/kg 3

For Bronchoscopy:

  • Maximum total dose: 8.2 mg/kg (approximately 29 ml of 2% solution for a 70 kg patient) 4
  • 2% lignocaine gel is preferred over spray for nasal anesthesia 4

For Intravenous Lidocaine Infusions:

  • Loading dose: 1.5 mg/kg given over 10 minutes 4
  • Maintenance infusion: 1.5 mg/kg/hour for no longer than 24 hours 4
  • Calculate using ideal body weight rather than actual body weight 4, 3

Special Population Considerations

  • Reduce doses by 30% in infants younger than 6 months 3
  • Use lower doses in elderly patients and those with liver or cardiac impairment 4, 1
  • For children over 3 years: Maximum dose should not exceed 3 mg/kg 1
  • For patients weighing less than 40 kg: Intravenous lidocaine infusions should be avoided 4

Concentration Selection

  • Lower concentrations (0.2-0.5%) allow for higher total doses to be administered safely 2
  • Concentrated solutions (1-2%) should not be used for infiltration techniques 2
  • For epidural anesthesia: 2-3 mL of the indicated concentration per dermatome 1

Important Safety Considerations

  • Do not exceed the maximum recommended dose to avoid local anesthetic systemic toxicity 3, 5
  • When using multiple local anesthetics concurrently, consider the additive effects 3
  • Do not use intravenous lidocaine within 4 hours of other local anesthetic interventions 4
  • Use epinephrine-containing solutions (typically 1:200,000) when larger volumes are required to reduce systemic absorption, unless contraindicated 1, 6
  • Monitor for signs of toxicity, which correlate directly with total dose administered 1, 5

Common Pitfalls to Avoid

  • Using actual body weight instead of ideal body weight in obese patients 4, 3
  • Administering too rapidly, which increases risk of toxicity 4
  • Not accounting for reduced clearance in patients with renal, hepatic, or cardiac disease 5
  • Failing to adjust dosage in highly vascular areas where systemic absorption is increased 3

Despite recommendations to limit the dose to 400 mg, studies have shown that higher doses (up to 622 mg) during bronchoscopy did not result in toxic serum levels or adverse effects 7, 8. However, it's prudent to use the minimum effective dose whenever possible.

References

Research

The dosage of dilute lignocaine for the infiltration technique of local analgesia.

Annals of the Royal College of Surgeons of England, 1991

Guideline

Maximum Dose Calculation for Local Anesthetics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Maximum recommended doses of local anesthetics: a multifactorial concept.

Regional anesthesia and pain medicine, 2004

Research

Serum concentrations of lignocaine before, during and after fiberoptic bronchoscopy.

Respiration; international review of thoracic diseases, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.